The prognostic value of circulating VEGF was addressed in one study [123], as patients with metastasis at diagnosis or within a year of diagnosis had significantly higher serum levels of VEGF than non-metastatic patients without early metastatic disease. Here, VEGFA is linked to metastatic neoplasm.